Zivo Bioscience Inc (ZIVO) — Strategic Asset Allocation Index
Zivo Bioscience Inc (ZIVO) has a Strategic Asset Allocation Index of 13.8% as of September 2022. Strategic assets (PP&E of $210.76K plus long-term investments of $-) total $210.76K, measured against net assets of $1.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ZIVO equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zivo Bioscience Inc Strategic Asset Allocation Index (2021–2021)
This chart shows how Zivo Bioscience Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 13.8%, representing strategic assets of $210.76K against net assets of $1.52 Million USD. For live market cap and overall valuation, see market value of Zivo Bioscience Inc.
Annual Strategic Asset Allocation Index for Zivo Bioscience Inc (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Zivo Bioscience Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Zivo Bioscience Inc (ZIVO) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.5% | $27.23K | $27.23K | $- | $6.04 Million | — |